ArticlePharmaceutical research2025
Drug Delivery and Binding in a Tissue with Irregularly Shaped Binding Regions.
Article in Pharmaceutical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveA fundamental understanding of drug diffusion and binding processes is critical for the design and optimization of a wide variety of drug delivery devices. Most of the past literature assume binding to occur uniformly throughout the tissue, or, at best, in specific layers of a multilayer tissue. However, in many realistic scenarios, such as in cancer-targeting drugs, drug binding occurs in discrete irregularly shaped regions.
methodsThis work presents mathematical modeling of drug diffusion and binding in a Cartesian tissue containing a number of irregularly shaped drug binding regions. Based on linear irreversible binding, an exact expression for the transient concentration distribution in the tissue, and thus, the amount of bound drug is derived. A comprehensive verification of the theoretical model, including comparison with past work, is presented.
resultsThe capability of the theoretical model to account for irregular non-Cartesian shapes of the drug binding regions is demonstrated by solving a number of illustrative problems. The impact of the location and size of a drug binding region on the extent of drug binding is determined. Comparison between a single large drug binding region and two smaller drug binding regions is carried out.
conclusionsThis work advances the literature on drug diffusion and binding by making it possible to account for realistic, irregular shapes of drug binding regions. The model may help design and optimize drug delivery processes and devices in the presence of realistic drug binding regions.
Indexed as
Identifiers
40931221What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.